Please login to the form below

Not currently logged in
Email:
Password:

Michael Wyzga OncoMed board

He brings financial experience from Genzyme

Michael Wyzga OncoMedOncoMed has appointed industry veteran Michael Wyzga to the company's board of directors.

The cancer specialist is looking to make the most of Wyzga's years in the industry as it prepares to advance the development of its five drug candidates, with several new filings planned for 2014.

This experience includes serving as chief financial officer of the biotech Genzyme from 1998 to 2011, when the company was acquired by Sanofi in what was the second-largest acquisition in biotech history.

He is currently president and CEO of biopharma company Radius Health having joined the company in December 2011.

"As a CEO of an emerging biopharmaceuticals company and previous chief financial officer of one of the leading biotechnology companies in the world, Mike brings an excellent perspective to OncoMed's board following our successful initial public offering," said Paul Hastings, chairman and CEO of OncoMed.

In addition to its own prospects, OncoMed also has development deals with major pharma companies, including GlaxoSmithKline and Bayer.

23rd October 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...